Science magazine names HIV drug its ‘Breakthrough of the Year’

Advisory Board December 19, 2024

Science last week named the HIV prevention drug lenacapavir as its 2024 Breakthrough of the Year, saying it represented “a pivotal step toward diminishing HIV/AIDS as a global health crisis.”

A breakthrough drug in HIV prevention

Although there have been significant advances in HIV treatments and prevention methods over the last few decades, more than 1 million people are still infected by the virus every year, and reducing the number of new infections has largely stalled.

However, a new drug called lenacapavir “might break the impasse,” Science writes. Lenacapavir, which is manufactured by Gilead Sciences, was first approved by FDA as a treatment for multi-drug-resistant HIV in 2022. Now, new research suggests that it may be effective in preventing...

Today's Sponsors

Today's Sponsor